JDRF’s Thomas P. Brobson Captivates St. Louis Audiences

With Diabetes Research Updates

(Photos by Dave Myers)

Living with T1D (type 1 diabetes) for 10 years puts Thomas P. Brobson, Breakthrough T1D’s national director of research investment opportunities, in the unique position to effectively communicate Breakthrough T1D’s cutting edge research and development activities.

Breakthrough T1D Greater Missouri and Southern Illinois Chapter hosted Brobson for a series of talks in early March.  “Tom covered the waterfront of Breakthrough T1D-funded early exploratory research to proof-of-concept and proof of efficacy clinical trials.  He answered a host of questions and clearly addressed the challenges Breakthrough T1D faces in the discovery, development and delivery of drugs and devices to cure, better treat and prevent T1D,” said Emily Rapp, Chapter Board President.  “Audience members were particularly moved to hear about his personal thrill – wearing the first generation artificial pancreas as part of a clinical trial.  There were plenty of goose bump moments hearing about other innovations farther in the future, as well.  We left with many reasons to hope. “

Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation) partners with the academic sector, other funders and foundations, industry, regulatory agencies, and payers on a world-wide basis and is currently funding research in academia in 18 different countries and has partnered with over 40 different companies in the last seven years.